These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17437815)

  • 1. Do tumor volume, tumor volume ratio, type of nerve sparing and surgical experience affect prostate specific antigen recurrence after laparoscopic radical prostatectomy? A matched pair analysis.
    Ates M; Teber D; Gözen AS; Tefekli A; Sugiono M; Hruza M; Rassweiler J
    J Urol; 2007 May; 177(5):1771-5; discussion 1775-6. PubMed ID: 17437815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Robot-assisted or pure laparoscopic nerve-sparing radical prostatectomy: what is the optimal procedure for the surgical margins? A single center experience.
    Koutlidis N; Mourey E; Champigneulle J; Mangin P; Cormier L
    Int J Urol; 2012 Dec; 19(12):1076-81. PubMed ID: 22860572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center.
    Albadine R; Hyndman ME; Chaux A; Jeong JY; Saab S; Tavora F; Epstein JI; Gonzalgo ML; Pavlovich CP; Netto GJ
    Hum Pathol; 2012 Feb; 43(2):254-60. PubMed ID: 21820147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
    Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
    Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
    Shikanov S; Song J; Royce C; Al-Ahmadie H; Zorn K; Steinberg G; Zagaja G; Shalhav A; Eggener S
    J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure.
    Palisaar RJ; Noldus J; Graefen M; Erbersdobler A; Haese A; Huland H
    Eur Urol; 2005 Feb; 47(2):176-84. PubMed ID: 15661411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin.
    You D; Jeong IG; Song C; Cho YM; Hong JH; Kim CS; Ahn H
    Int J Urol; 2014 May; 21(5):484-9. PubMed ID: 24256352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic radical prostatectomy in clinical T1a and T1b prostate cancer: oncologic and functional outcomes--a matched-pair analysis.
    Teber D; Cresswell J; Ates M; Erdogru T; Hruza M; Gözen AS; Rassweiler J
    Urology; 2009 Mar; 73(3):577-81. PubMed ID: 19100598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report.
    Li K; Li H; Yang Y; Ian LH; Pun WH; Ho SF
    Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.
    Mandel P; Oh SJ; Hagner C; Tennstedt P; Kriegmair MC; Huland H; Graefen M; Tilki D
    World J Urol; 2016 Nov; 34(11):1547-1553. PubMed ID: 27003277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer.
    Nelson BA; Shappell SB; Chang SS; Wells N; Farnham SB; Smith JA; Cookson MS
    BJU Int; 2006 Jun; 97(6):1169-72. PubMed ID: 16686706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence.
    Cao D; Kibel AS; Gao F; Tao Y; Humphrey PA
    Am J Surg Pathol; 2010 Jul; 34(7):994-1001. PubMed ID: 20505501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
    J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.
    Schlomm T; Tennstedt P; Huxhold C; Steuber T; Salomon G; Michl U; Heinzer H; Hansen J; Budäus L; Steurer S; Wittmer C; Minner S; Haese A; Sauter G; Graefen M; Huland H
    Eur Urol; 2012 Aug; 62(2):333-40. PubMed ID: 22591631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
    Carver BS; Bianco FJ; Scardino PT; Eastham JA
    J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.